“…Like other bacterial pathogens, M. tuberculosis have evolved to secrete effector proteins, including an effector kinase, PknG, to counteract host defense and promote infection (Walburger et al, 2004;Nicholson and Champion, 2022). The kinase activity of PknG is essential to M. tuberculosis pathogenicity (Walburger et al, 2004) and has therefore been a potential antibiotic target for tuberculosis treatments (Gil et al, 2013;Swain et al, 2021). Studies in PknG's role in pathogenesis show that this effector contains versatile activities, such as E3-ubiquitin ligase activity for host protein ubiquitination Shariq et al, 2022) and regulatory activity for metabolism, virulence, and stress response within M. tuberculosis (Khan et al, 2017;Rieck et al, 2017;Lima et al, 2021).…”